Search Results - "Naipal, Kishan A T"
-
1
Tumor slice culture system to assess drug response of primary breast cancer
Published in BMC cancer (09-02-2016)“…The high incidence of breast cancer has sparked the development of novel targeted and personalized therapies. Personalization of cancer treatment requires…”
Get full text
Journal Article -
2
Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
Published in PloS one (14-12-2018)“…Bladder cancer (urothelial carcinoma) is a common malignancy characterized by high recurrence rates and intense clinical follow-up, indicating the necessity…”
Get full text
Journal Article -
3
Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer
Published in PloS one (30-04-2015)“…Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum…”
Get full text
Journal Article -
4
Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatment
Published in Clinical cancer research (15-09-2014)“…Poly(ADP-ribose) polymerase (PARP) inhibitors are promising targeted treatment options for hereditary breast tumors with a homologous recombination (HR)…”
Get full text
Journal Article -
5
Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series
Published in Pharmacology research & perspectives (01-06-2023)“…Mycophenolate mofetil has an important role as immunosuppressive agent in solid organ transplant recipients. Exposure to the active mycophenolic acid (MPA) can…”
Get full text
Journal Article -
6
Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
Published in Clinical cancer research (15-12-2018)“…Tumors of germline mutated carriers show homologous recombination (HR) deficiency (HRD), resulting in impaired DNA double-strand break (DSB) repair and high…”
Get full text
Journal Article -
7
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
Published in Future science OA (01-05-2017)“…Optimal patient stratification is of utmost importance in the era of personalized medicine. Prediction of individual treatment responses by functional assays…”
Get full text
Journal Article -
8
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
Published in The New England journal of medicine (07-11-2024)“…Among patients who received two 3-week cycles of neoadjuvant ipilimumab and nivolumab, the 12-month event-free survival was 83.7%, as compared with 57.2% among…”
Get full text
Journal Article -
9
Correction: Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
Published in Clinical cancer research (01-05-2019)Get full text
Journal Article -
10
Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer: e0126029
Published in PloS one (01-04-2015)“…Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum…”
Get full text
Journal Article